Order & collect
The ordering clinician requests the panel and a buccal swab is collected for laboratory analysis.
PROXIGENE PGx · PHARMACOGENOMICS
ProxiGene PGx
Genetic insights for prescribing decisions.
ProxiGene PGx is a provider-ordered pharmacogenomics panel that translates inherited variation into a structured, clinically oriented report. BioMed Partners connects practices and health systems with the HealthSpan360 team to explore implementation.
34genes, HLA loci & pharmacodynamic markers
14therapeutic categories
1buccal swab, provider ordered
FROM SAMPLE TO ACTION
Designed for the clinical decision.
Analyze & interpret
The assay evaluates selected metabolism, transporter, HLA and pharmacodynamic markers. Results are interpreted with reference to CPIC, DPWG, FDA and PharmGKB resources.
Review & apply
A clinician action summary prioritizes major and moderate findings, followed by therapeutic assessments, genotype details, methods and citations. The prescriber considers the result alongside the full clinical picture.
WHAT MAKES THE REPORT USEFUL
See the action first. Inspect the evidence beneath it.
Severity-ranked findings
Potential gene–drug interactions are triaged with drug or dose considerations where the report supports them.
Transparent scope
Diplotype and phenotype calls, including no-action findings, accompany the list of alleles interrogated.
Evidence with context
Findings are organized by therapeutic area and include guideline or labeling references to support clinician review.
POTENTIAL CLINICAL APPLICATIONS
Relevant across specialties.
Examples illustrate gene–drug areas included in the source materials; a result does not determine treatment on its own.
PROVIDER MATERIALS
Explore the full ProxiGene package.
Review the PGx overview and provider presentation, then discuss ordering and clinical workflow with our team.